Filed before 2025Filed 16 November 2017
Nohla Therapeutics Inc. has sold $32.4M so far
Nohla Therapeutics Inc., a biotech company based in Seattle, WA, has sold $32.4M so far in its equity round, according to a filing dated 16 November 2017.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 16 November 2017
- First filed
- 5 December 2016
- Round
- Equity round (amended filing)
- Amount sold
- $32.4M
- Offering size
- $41.5M
- Investors so far
- 13
- Based in
- Seattle, WA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 90% of the 1,645 tracked raises with an amount filed in 2017, and than 82% of the 152 in biotech.
Nohla Therapeutics Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 16 May 2018 | New filing | $45M | Another raise |
| 16 Nov 2017 | Amended filing | $32.4M | This raise |
| 5 Dec 2016 | New filing | $12M | This raise |
More with ARCH on the board
- SonoThera, Inc.$125M
- Ollin Biosciences, Inc.$156M
- Vizgen, Inc.$47.8M
- Pheast Therapeutics, Inc.$24.6M
Other unannounced rounds
- Thoughtform, Inc.$6.6M
- ProvenAir Technologies, Inc.$488K
- Gravitics, Inc.$17M
- SurgiBox Inc.$486K
- Voxel Labs Inc.$10M
- DVx Atomic Co.$18.5M
Seen it announced?
Send the link and the check will look at it.